Australia's largest stock trading and investment forum Australia's #1 stock forum

KZA

Click for more information

0.00%

8.0¢ kazia therapeutics limited

Ann: Change in substantial holding, page-35

First 35 Last

Share
Profile

Follow
novogenbuyer

856 Posts.

356

28/05/20

02:59

Post #: 44881187
Share

Originally posted by onesurfed: ↑
KZIA HEALTH CARE 550,000

59 550,000 New 7.6212% Q1 2020 2.90 13F 2020-03-31 2020-05-15
I tried to edit out the line "no data available in table" but couldn't.
From page 5 of list of their holdings, the estimated average price paid for shares is US $2.90. That's above where it is now. To figure what their real cost was per KZA share, you'd have to know what the average currency exchange rate between Australia and U.S. was when they were buying the shares.

You're right, who knows what they've been doing?

I personally think that their grand plan for a big score on the AACR announcement was foiled by the CR.
Expand
I don't know why the holding didn't trigger a 13G filing since they clearly owned more than 5% of the company at that time. I also wonder why the value of the shares is listed as "0" on the official 13F filing (https://www.sec.gov/Archives/edgar/data/1491072/000131586320000463/xslForm13F_X01/ansonfunds1q20.inftab.xml).

KZA Price at posting: 41.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

There are more pages in this discussion • 1 more message in this thread...

First 35 Last

Add KZA (ASX) to my watchlist